GM26594
Fibroblast from Skin, Arm
Description:
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
N-GLYCANASE 1; NGLY1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Biopsy Source
|
Arm
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Arm
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
Irish/German
|
Country of Origin
|
USA
|
Family Member
|
3
|
Family History
|
N
|
Relation to Proband
|
mother
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
6.17 |
Passage Frozen |
5 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
NGLY1 |
Chromosomal Location |
3p24.2 |
Allelic Variant 1 |
p.G310G; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG |
Identified Mutation |
GLY310GLY; The NGLY1 gene encodes N-glycanase (EC 3.5.1.52), a highly conserved enzyme that catalyzes deglycosylation of misfolded N-linked glycoproteins by cleaving the glycan chain before the proteins are degraded by the proteasome (Zhou et al., 2006). NGLY1 is a cytoplasmic component of the endoplasmic reticulum-associated degradation (ERAD) pathway that identifies and degrades misfolded glycoproteins (summary by Enns et al., 2014). |
|
Gene |
CACNA1S |
Chromosomal Location |
1q32.1 |
Allelic Variant 1 |
; MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5 |
Identified Mutation |
THR1354SER; The major type of voltage-sensitive Ca(2+) channels in skeletal muscle is the slowly inactivating L-type that is sensitive to calcium channel blockers such as 1,4-dihydropyridines (DHP), phenylalkylamines, and benzothiazepines. These skeletal muscle Ca(2+) channels play a key role in excitation-contraction coupling, a process whereby electrical signals generated by action potentials at the muscle cell surface are transduced into intracellular release of calcium and ultimately muscle fiber contraction. The DHP-sensitive L-type Ca(2+) channel from skeletal muscle is an oligomeric protein composed of 2 high molecular weight polypeptide subunits (alpha-1 and alpha-2) and 3 smaller units (beta, gamma, and delta). |
Remarks |
Unaffected carrier; mother (GM26593 lymph) of affected child (GM25344 fibro; GM25330 lymph); affected daughter (GM25331 lymph and GM25343 fibro) ; heterozygous mutation (c.930C>T) in exon 6 of NGLY1 gene resulting in p.Gly310Gly; genetic testing also showed heterozygous mutation (c.4060 A>T) in exon 33 of the CACNAIS gene resulting in p.Thr1354Ser; maternal cousin of affected children died at 3 weeks of age from aortic stenosis; distant maternal relative has Down Syndrome; distant maternal relative has cleft lip and palate; distant maternal relative died in adolescence from congenital heart disease. |
Passage Frozen |
5 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|